Authors
Latest:
Commercial Sustainability of Pharmaceutical Innovations for PandemicsAssessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.
Latest:
Developing a Product Launch Strategy for an Orphan DrugCommercializing an orphan drug can be challenging, however, using a framework and a checklist that incorporates the right elements can prove beneficial.
Latest:
Securities Litigation Arising from Alzheimer's Drug TreatmentsThe legal challenges surrounding Biogen’s Aduhelm and Cassava Sciences’ simufilam underscore the ongoing difficulties in Alzheimer's drug development, leading to securities litigation over allegedly misleading statements about trial results and commercialization efforts.
Latest:
How AI is Revamping the Product LaunchNew technology is allowing teams to analyze data at faster rates and make decisions much sooner than they previously could.
Latest:
Rx Power Struggle: How Pharma can Flip the PBM ScriptThe industry holds the key to true change to the drug access landscape.
Latest:
Validating COAs: Key Steps for Accurate and Reliable Clinical Trial DataWith the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in recent decades.
Latest:
How Technology Can be Used to Improve AdherenceComprehensive dosage monitoring of topical treatments for mild to moderate psoriasis.
Latest:
Turning COVID-19 Era Regulatory Efficiencies into Long-term Business Growth and InnovationCOVID-19 pandemic sets new standards for life sciences industry.
Latest:
Understanding Healthcare Access Barriers: Industry Trends and the Patient Assistance ApproachWebinar Date/Time: Thu, Mar 28, 2024 2:00 PM EDT
Latest:
The Interplay Between COVID-19 Pandemic and NCD EpidemicAmid attention on coronavirus, efforts to address the burden of non-communicable diseases are at a critical juncture.
Latest:
Propelling Medical Innovation Forward in Pharma R&DWith uncertainty surrounding the future of government funding, the onus is being placed on the private sector to continue driving new discoveries.
Latest:
Combating the Opioid Crisis With Long-Acting InjectablesSubstance use disorder is a complex condition that demands innovative solutions, one of which that has shown promise is the use of long-acting injectables.
Latest:
Investing for Success: Finding the Right Launch BalanceChallenge assumptions and reset expectations when it comes to pre-launch SG&A investment to increase the odds of commercial success.
Latest:
China’s Trial Advantage: Tracking Nation’s Growth in Pharma Innovation and Global InvestmentA look at China's emergence as a hub for novel treatment pursuits—and ways international investors can best capitalize on the favorable research trajectory.
Latest:
Clues on Equity Engagement LevelsA survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.
Latest:
Data Intermediaries/Software Can Speed the Usage of Real-World DataSurvey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data.
Latest:
The New Era of HCP Engagement: What’s Next on the Path to Digital ExcellenceCompanies now have a unique opportunity to rethink their customer engagement strategy and find new techniques to serve healthcare professionals more effectively.
Latest:
AI-Driven Analytics: From Competitive Advantage to Essential Business ToolMeeting the growing need and demand for fast information to make optimal and timely treatment decisions.
Latest:
Strategic Decision-Making in Early-Stage Drug Development and Lifecycle Management to Maximize a Drug’s Lifetime ValuePresenting a structured, decision-making approach for executive management to make sound strategic decisions for drug development and life cycle management.
Latest:
A Dogged DevotionSaving and transforming as many patients’ lives as possible has been the driving force behind Beth Seidenberg’s audacious career, where she has excelled as a doctor, researcher, and venture capitalist.
Latest:
From Science to Sales: Leveraging Medical Affairs for Commercial TriumphMarketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.
Latest:
Partnering to Respond to a Possible Nuclear ThreatRecent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Latest:
Unlocked Potential — ‘Keying’ in On New-Era EngagementHow adoption of the key account management (KAM) model can help drive pharma’s agility in reaching and influencing a more diverse set of healthcare customers and decision-makers.
Latest:
Patients Are Ready for a Digital Future, Here’s Pharma’s Path Toward the Next Growth HorizonRecent advances from COVID-19 vaccine development put pharma in place to further grow relationship with patients.
Latest:
Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial SuccessThe traditional biopharma approach focused primarily on physician detailing and securing favorable payer contracts, has become inadequate in today’s market.
